Cargando…
A combined signature of glycolysis and immune landscape predicts prognosis and therapeutic response in prostate cancer
Prostate cancer (PCa) is a common malignancy that poses a major threat to the health of men. Prostate-specific antigen (PSA) and its derivatives, as FDA-approved detection assays, are insufficient to serve as optimal markers for patient prognosis and clinical decision-making. It is widely acknowledg...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634133/ https://www.ncbi.nlm.nih.gov/pubmed/36339430 http://dx.doi.org/10.3389/fendo.2022.1037099 |